Monthly injection helps severe asthma patients safely stop or reduce daily steroids
A monthly injection has helped 90% of severe asthma patients reduce daily steroid tablets, which are associated with long-term side effects.
More than half of the participants who had received the injection were able to stop their daily steroid tablets entirely, without any impact on their symptoms.
The clinical trial led by a King’s College London academic followed patients who had been injected with tezepelumab every four weeks for a year. Tezepelumab is a type of antibody which targets parts of the immune system, reducing lung inflammation.
Treatment with tezepelumab was also shown to significantly improve asthma symptoms, lung function, and overall quality of life. During ...